Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Malignant Solid Tumour × Hydroxychloroquine × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Refractory or Relapsed Solid Tumors 1 Prostate Cancer Recurrent 1 Malignant Solid Tumour 1 Bone Metastases 1

Interventions

Vorinostat 2 pembrolizumab 1 nintedanib 1 dactolisib 1 avelumab 1 Vinorelbine 1 Sunitinib 1 Oxaliplatin 1 Levoleucovorin 1 Leucovorin 1 Hydroxychloroquine 1 Folfox protocol 1 Fluorouracil 1 Dasatinib 1 DOXO-EMCH 1 Cetuximab 1 Bevacizumab 1 BN 80927 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01023737 2023-02-13

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

The University of Texas Health Science Center at San Antonio

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡